Emgrast M 500mcg Injection
By Emgrast M
Rx
1 Injection in a Vial

Composition
Sargramostim(500mcg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
January, 2027

liver
For individuals with liver disease, it is important to be cautious when using Emgrast M 500mcg Injection. Adjustments to the dosage of the injection may be necessary in such cases, therefore consulting with your doctor is crucial. It is recommended to undergo regular monitoring of liver function tests while using this medicine to ensure the liver is functioning properly.

kidney
Emgrast M 500mcg Injection requires caution in patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Regular kidney function tests are recommended during treatment.

alcohol
It is uncertain if drinking alcohol with Emgrast M 500mcg Injection is safe. Consult your doctor.

driving
It is unclear if Emgrast M 500mcg Injection affects driving. Avoid driving if you have symptoms that hinder focus and reaction time while using this medication.

pregnancy
Emgrast M 500mcg Injection should be used with caution during pregnancy. Limited human studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Emgrast M 500mcg Injection is likely safe during breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) |
Therapeutic Class | - |
Action Class | Granulocyte-macrophage colony stimulating factor (GM-CSF) |
₹3582
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025